Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Gatz · SciRah

Researcher profile · Semantic Scholar

S. Gatz

Share profile

S. Gatz — researcher profile on SciRah

h-index: 23
Works: 66
Citations: 1,824

Most-cited papers

p53 in recombination and repair
S. Gatz, L. Wiesmüller
2006Cell Death and Differentiation256 citations
Semantic Scholar
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium
J. Shern, Joanna L Selfe, E. Izquierdo, R. Patidar +28 more
2021Journal of Clinical Oncology179 citations Open access
Semantic Scholar
SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
Catharina Schuetz, B. Neven, C. Dvorak, S. Leroy +18 more
2014Blood152 citations Open access
Semantic Scholar
Role of SIRT1 in homologous recombination.
Miriam Uhl, Andreea Csernok, S. Aydın, R. Kreienberg +2 more
2010DNA Repair96 citations
Semantic Scholar
Take a break--resveratrol in action on DNA.
S. Gatz, L. Wiesmüller
2008Carcinogenesis85 citations
Semantic Scholar
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.
S. Hettmer, C. Linardic, A. Kelsey, E. Rudzinski +18 more
2022European Journal of Cancer70 citations Open access
Semantic Scholar
Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
A. Ferrari, B. Brennan, M. Casanova, N. Corradini +11 more
2022Cancer Management and Research66 citations Open access
Semantic Scholar
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
Sally L. George, E. Izquierdo, James J. Campbell, Eleni Koutroumanidou +33 more
2019European Journal of Cancer66 citations Open access
Semantic Scholar
Development/Plasticity/Repair Requirement for DNA Ligase IV during Embryonic Neuronal Development
S. Gatz, Limei Ju, R. Gruber, E. Hoffmann +4 more
2011Journal of Neuroscience65 citations Open access
Semantic Scholar
Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR-p53- and -Nbs1-dependent manner.
S. Gatz, M. Keimling, Cindy A. Baumann, T. Dörk +3 more
2008Carcinogenesis61 citations Open access
Semantic Scholar
The Future of Precision Oncology
S. Rulten, R. Grose, S. Gatz, J. Jones +1 more
2023International Journal of Molecular Sciences54 citations Open access
Semantic Scholar
Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
J. Chisholm, H. Mandeville, Madeleine Adams, V. Minard-Collin +23 more
2024Cancers52 citations Open access
Semantic Scholar
Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases.
A. Schulz, G. Glatting, M. Hoenig, Catharina Schuetz +11 more
2011Blood52 citations Open access
Semantic Scholar
Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft Tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial
A. Defachelles, E. Bogart, M. Casanova, J. H. Merks +12 more
2021Journal of Clinical Oncology45 citations Open access
Semantic Scholar
Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease
Catharina Schuetz, M. Hoenig, S. Gatz, F. Speth +4 more
2008Immunologic research41 citations Open access
Semantic Scholar
Toxicity and Outcome of Children and Adolescents Participating in Phase I/II Trials of Novel Anticancer Drugs: The Royal Marsden Experience
D. Morgenstern, D. Hargrave, L. Marshall, S. Gatz +9 more
2014Journal of pediatric hematology/oncology31 citations
Semantic Scholar
Circulating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours
Reda Stankunaite, Sally L. George, Lewis Gallagher, S. Jamal +27 more
2021European Journal of Cancer28 citations Open access
Semantic Scholar
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study
O. Ruhen, N. Lak, J. Stutterheim, S. Danielli +32 more
2022JCO Precision Oncology26 citations Open access
Semantic Scholar
Desmoplastic small round cell tumor: from state of the art to future clinical prospects
S. Hovsepyan, C. Giani, S. Pasquali, A. Di Giannatale +10 more
2023Expert Review of Anticancer Therapy25 citations Open access
Semantic Scholar
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting
S. Pomella, M. Cassandri, Lucrezia D'Archivio, A. Porrazzo +36 more
2023Nature Communications23 citations Open access
Semantic Scholar
Experimental Models
S. Gatz, Janet Shipley, C. Keller, C. Linardic
2020Sarcomas of Bone and Soft Tissues in Children and Adolescents23 citations
Semantic Scholar
Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategy
Antonio Romo-Morales, E. Aladowicz, J. Blagg, S. Gatz +1 more
2019Pediatric Blood & Cancer23 citations Open access
Semantic Scholar
MCM3AP and POMP Mutations Cause a DNA‐Repair and DNA‐Damage‐Signaling Defect in an Immunodeficient Child
S. Gatz, Daniela Salles, Eva Jacobsen, T. Dörk +14 more
2016Human Mutation23 citations
Semantic Scholar
Multifocal osteomyelitis caused by Candida dubliniensis.
N. Wellinghausen, A. Moericke, Silke Bundschuh, W. Friedrich +2 more
2009Journal of Medical Microbiology23 citations Open access
Semantic Scholar
Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours
E. Izquierdo, Lina Yuan, Sally L. George, M. Hubank +20 more
2017bioRxiv20 citations Open access
Semantic Scholar
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
A. Pearson, Sara M. Federico, S. Gatz, M. Ortiz +37 more
2023European Journal of Cancer18 citations Open access
Semantic Scholar
A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
S. Gatz, E. Aladowicz, M. Casanova, J. Chisholm +5 more
2019Frontiers in Oncology18 citations Open access
Semantic Scholar
Randomized phase 2 trial of the combination of vincristine and irinotecan with or without temozolomide, in children and adults with refractory or relapsed rhabdomyosarcoma (RMS).
A. Defachelles, E. Bogart, M. Casanova, H. Merks +12 more
2019Journal of Clinical Oncology18 citations
Semantic Scholar
FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas
Christopher I. Milton, Joanna L Selfe, E. Aladowicz, S. Man +17 more
2021Molecular Oncology17 citations Open access
Semantic Scholar
Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States
Sally L. George, Claire Lynn, Reda Stankunaite, Debbie Hughes +50 more
2024Cancer Discovery16 citations Open access
Semantic Scholar
AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial
B. Geoerger, Xavier Paoletti, Francisco Bautista, S. Gatz +18 more
2023Nature Medicine16 citations Open access
Semantic Scholar
Chemotherapy responsiveness in a patient with multiply relapsed ameloblastic fibro‐odontosarcoma of the maxilla
S. Gatz, K. Thway, H. Mandeville, C. Kerawala +2 more
2015Pediatric Blood & Cancer16 citations Open access
Semantic Scholar
Phase I/II study of the WEE1 inhibitor adavosertib (AZD1775) in combination with carboplatin in children with advanced malignancies: Arm C of the AcSé-ESMART trial.
S. Gatz, A. C. Harttrampf, C. Brard, Francisco Bautista +19 more
2023Clinical Cancer Research13 citations Open access
Semantic Scholar
Shedding a Light on the Challenges of Adolescents and Young Adults with Rhabdomyosarcoma
A. Ferrari, S. Gatz, V. Minard-Colin, R. Alaggio +15 more
2022Cancers13 citations Open access
Semantic Scholar
Precision cancer medicine platform trials: Concepts and design of AcSé-ESMART.
B. Geoerger, Francisco Bautista, Nicolas André, P. Berlanga +16 more
2024European Journal of Cancer11 citations
Semantic Scholar
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium.
A. Juan-Ribelles, A. Félix, N. Benavent, Josep Escrivá-Fernández +11 more
2025JCO Precision Oncology10 citations Open access
Semantic Scholar
Controversies on the possible role of immune checkpoint inhibitors in pediatric cancers: balancing irAEs and efficacy
O. Nigro, A. Ferrari, M. Casanova, D. Orbach +4 more
2021Tumori10 citations
Semantic Scholar
Targeted resequencing of pediatric rhabdomyosarcoma: report from the Children’s Oncology Group, the Children’s Cancer and Leukaemia Group, The Institute of Cancer Research UK, and the National Cancer Institute.
J. Shern, R. Patidar, Y. Song, Ashley Walton +16 more
201810 citations
Semantic Scholar
Treatment at Relapse for Synovial Sarcoma of Children, Adolescents and Young Adults: From the State of Art to Future Clinical Perspectives
Andrea Ferrari, P. Berlanga, S. Gatz, R. Schoot +12 more
2023Cancer Management and Research8 citations Open access
Semantic Scholar
AcSé-ESMART: European Proof of Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors in Children and Adolescents–Arm D: Olaparib and irinotecan.
S. Gatz, Jonathan Rubino, C. Rossoni, N. André +9 more
2019Journal of Clinical Oncology8 citations
Semantic Scholar
Abstract CT088: Phase I/II study of the PARP inhibitor olaparib in combination with irinotecan in children with advanced malignancies: arm D of the AcSé-ESMART trial
S. Gatz, P. Berlanga, Baptiste Archambaud, Y. Bouchoucha +22 more
2023Cancer Research7 citations
Semantic Scholar
A Case of Selective Mutism in an 8-Year-Old Girl with Thalassaemia Major after Bone Marrow Transplantation
P. Plener, S. Gatz, C. Schuetz, A. Ludolph +1 more
2009Pharmacopsychiatry7 citations Open access
Semantic Scholar
Relapsed rhabdomyosarcoma: treatment recommendations from the European pediatric soft tissue sarcoma study group (EpSSG)
A. Defachelles, W. Breunis, M. Casanova, V. Minard-Collin +10 more
2025British Journal of Cancer5 citations Open access
Semantic Scholar
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3–FOXO1 rhabdomyosarcoma
F. Aiello, Lucrezia D'Archivio, Marika Attili, E. Ferraro +22 more
2025Cell Death Discovery4 citations Open access
Semantic Scholar
Childhood, Adolescent and Young Adult Poor-Prognosis Rhabdomyosarcoma
A. Wasti, G. Bisogno, R. Hladun, A. Defachelles +16 more
2025Cancers4 citations Open access
Semantic Scholar
A dual readout embryonic zebrafish xenograft model of rhabdomyosarcoma to assess clinically relevant multi-receptor tyrosine kinase inhibitors
Joseph W. Wragg, E. Gray, Rui Monteiro, J. Morris +3 more
2024bioRxiv4 citations Open access
Semantic Scholar
Phase I/II study of the PARP inhibitor olaparib and irinotecan in children and young adults with recurrent/refractory malignancies: Arm D of the AcSé-ESMART trial.
S. Gatz, P. Berlanga, G. Le Teuff, Ivan Valiev +35 more
2026Clinical Cancer Research2 citations Open access
Semantic Scholar
A new generation of comprehensive precision oncology trials.
B. Geoerger, Francisco Bautista, S. Gatz, L. Marshall +1 more
2023The Lancet Oncology2 citations
Semantic Scholar
Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma
K. Hebron, P. Odeniyide, Yun Wei, B. Gryder +36 more
2026Cancers1 citations Open access
Semantic Scholar
Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder Analysis
S. Gatz, J. Glade-Bender, A. D. Pearson, M. Ortiz +26 more
2026JCO Precision Oncology1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Casanova×13
Invite
M. Casanova — researcher profile on SciRah
J. Chisholm×11
Invite
J. Chisholm — researcher profile on SciRah
J. Shipley×10
Invite
J. Shipley — researcher profile on SciRah
P. Berlanga×8
Invite
P. Berlanga — researcher profile on SciRah

Sally L. George

×7

Invite

Sally L. George — researcher profile on SciRah

Invite

L. Chesler — researcher profile on SciRah

Invite

L. Marshall — researcher profile on SciRah

A. Defachelles×7

Invite

A. Defachelles — researcher profile on SciRah

Invite

G. Bisogno — researcher profile on SciRah

Invite

A. Wasti — researcher profile on SciRah

Jonathan Rubino×6

Invite

Jonathan Rubino — researcher profile on SciRah

L. Wiesmüller×5

Invite

L. Wiesmüller — researcher profile on SciRah